Overexpression of EZH2 is able to activate the PI3K/AKT pathway, by which BRCA1 (a tumor suppressor) were exported from nuclei, and aneuploidy and mitotic deficiency were elicited, leading to invasive breast cancer [39]. Here, EZH2 is linked to invasive breast carcinoma.